Form 4 for AVBP ArriVent BioPharma, Inc.
Accepted 2024-09-23 00:00:00 ET · period of report 2024-09-19 · accession 0001104659-24-102146 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-23 | 2024-09-19 | AVBP | LaChapelle Robin | COO | M - OptEx | $3.28 | +27.6K | 102.6K | +37% | +$90.5K |
| DM | 2024-09-23 | 2024-09-19 | AVBP | LaChapelle Robin | COO | M - OptEx | $0.00 | -27.6K | 56.5K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-19 | M | A | 2,471 | $2.28 | 112,219 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-19 | M | A | 12,364 | $3.65 | 124,583 | D | — | — | |
| 3 | Common | Common Stock | 2024-09-19 | M | A | 7,164 | $2.28 | 109,748 | D | — | — | |
| 4 | Common | Common Stock | 2024-09-19 | M | A | 2,700 | $6.24 | 99,717 | D | — | — | |
| 5 | Common | Common Stock | 2024-09-19 | M | A | 2,867 | $2.28 | 102,584 | D | — | — | |
| 6 | Derivative | Stock Option (right to buy) | 2024-09-19 | M | D | 2,471 | $0.00 | 2,460 | D | $2.28 · — to 2031-09-07 | 2,471 Common Stock | (F2) The shares underlying this option vested as to 25% on September 8, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. |
| 7 | Derivative | Stock Option (right to buy) | 2024-09-19 | M | D | 2,867 | $0.00 | 22,637 | D | $2.28 · — to 2032-01-31 | 2,867 Common Stock | (F3) The shares underlying this option vested as to 25% on February 1, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. |
| 8 | Derivative | Stock Option (right to buy) | 2024-09-19 | M | D | 7,164 | $0.00 | 15,473 | D | $2.28 · — to 2032-01-31 | 7,164 Common Stock | (F3) The shares underlying this option vested as to 25% on February 1, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. |
| 9 | Derivative | Stock Option (right to buy) | 2024-09-19 | M | D | 12,364 | $0.00 | 18,865 | D | $3.65 · — to 2033-01-31 | 12,364 Common Stock | (F4) The shares underlying this option vested as to 25% on February 1, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. |
| 10 | Derivative | Stock Option (right to buy) | 2024-09-19 | M | D | 2,700 | $0.00 | 56,471 | D | $6.24 · — to 2033-08-21 | 2,700 Common Stock | (F5) The shares underlying this option vested as to 25% on August 22, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. |